Clinical Trials Logo
  1. Home
  2. Clinical Pregnancy Rate
  3. NCT03162315
  4. Details
NCT03162315 Clinical Trial

The Value of Progesterone for the Timing of the Embryo Transfer in IVF/ICSI: a Prospective Randomised Trial

Clinical Pregnancy Rate Clinical Trial

Official title:
The Value of Progesterone for the Timing of the Embryo Transfer in IVF/ICSI: a Prospective Randomised Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03162315
Other study ID # B670201627451
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 2016
Est. completion date August 3, 2018

Study information
Verified date October 2019
Source University Hospital, Ghent
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

At the start of the controlled ovarian stimulation as a part of the IVF/ICSI treatment patients are informed about this trial. In case they gave informed consent and they have a progesterone level between 1 and 1.5 ng/ml at the day of the hCG injection, they will be randomised. One group of patients will have a fresh embryo transfer, in the second group all embryos will be cryopreserved and transfered in a subsequent (natural or artificial) cycle. The aim of this study is to compare clinical pregnancy rate between the two groups.

Recruitment information / eligibility
Status Completed
Enrollment 24
Est. completion date August 3, 2018
Est. primary completion date August 3, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- IVF/ICSI treatment

- progesterone > 1 ng/ml and = 1.5 ng/ml

Exclusion Criteria:

- > 40 years

- AMH = 1 ng/ml

- Conditions influencing pregnancy rate (e.g. hydrosalphinx, uterus malformation, hyperprolactinemia and other endocrine conditions; with the exception of controlled thyroid function disease)

- no available progesterone value on the day of hCG-injection

Study Design

Related Conditions & MeSH terms

Intervention

Procedure:
• Freeze all

Locations
Country Name City State
Belgium Ghent University Hospital - Department of Reproductive Medicine Ghent

Sponsors (1)
Lead Sponsor Collaborator
University Hospital, Ghent

Country where clinical trial is conducted

Belgium, 

Outcome
Type Measure Description Time frame Safety issue
Primary Clinical pregnancy rate 7 gestational weeks
Secondary Ongoing pregnancy rate 25 gestational weeks
Secondary Live birth rate Delivery
See also
  Status Clinical Trial Phase
Completed NCT03350646 - Does the Volume of the Embryo Culture Medium During Embryo Transfer Affects the IVF Outcomes? N/A
Completed NCT04175990 - IVF Outcome Following Progestogen Ovarian Stimulation Phase 1
Recruiting NCT02496754 - The Application of a New Ovarian Stimulation Protocol in IVF N/A
Recruiting NCT03006406 - Effect of Shorten Gonadotropin-releasing Hormone Agonist Therapy on the Outcome of in Vitro Fertilization-Embryo Transfer in Patients With Endometriosis N/A
Recruiting NCT06165367 - Hyaluronan-enriched Medium and Euploid Blastocyst Transfers N/A
Terminated NCT00737984 - Improving the Pregnancy Rate With Endometrial Sampling Before Intrauterine Insemination N/A